Lung Cancer Trials Ask AI to find trials
TerminatedPhase 2NCT02410382
Official study title

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

Study summary

This study will look at how dexamethasone and placebo influence radiation fatigue, quality of life and number of treatment days missed during radiation therapy or radiation therapy and chemotherapy for cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedDexamethasone and Placebo

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 14, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 2

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Arizona

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 2
Sponsor
University of Arizona
Interventions being studied
Drug: Dexamethasone; Drug: Placebo
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type
Non-small cell lung cancer (NSCLC)→
Treatment approach
Chemotherapy→Radiation therapy→
Study topics
Survivorship and quality of life→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • confirmation of head \& neck cancer (stage I-IV) or non-small cell lung cancer (stage II \& III)
  • Undergoing treatment with either radiation alone or in combination with chemotherapy
  • Normal cognition and willingness to complete fatigue and quality of life forms, patient observation form, and pill diary
Reasons someone may not be able to joinExclusion criteria
  • Hypersensitivity to dexamethasone or corticosteroids or Equal sugar substitute
  • Corticosteroid within the past 30 days prior to study enrollment for greater than one week duration
  • Planned Stereotactic Body Radiation Therapy (SBRT)
  • Active psychosis
  • Current pregnancy
  • Active peptic ulcer disease or evidence of gastrointestinal bleed
  • Current active tuberculosis or systemic fungal infection
  • Previous diagnosis of diabetes mellitus
  • Acute febrile illness
  • Known human immunodeficiency virus or acquired immunodeficiency syndrome
  • Major surgery within two weeks of study enrollment of which the patient has not recovered
  • Psychostimulant use in the past 30 days prior to registration
  • History of phenylketonuria (PKU)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of ArizonaTucson, Arizona

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 14, 2019. Always confirm current availability with the study team.

View original record ↗